αs1-CN f (initiaal

αs1-CN f (143–149) acetate is an orally active casein-derived peptide sequence. αs1-CN f (143–149) acetate exhibits angiotensin-converting enzyme (ACE) inhibitory activity (IC50=6.58 μM) and antihypertensive activity[1].

12352209

Angiotensin-converting Enzyme (ACE)

Metabolic Enzyme/Protease

Cardiovascular Disease

99.32

OC(C=C1)=CC=C1C[C@H](NC([C@@H](NC([C@@H](NC([C@@H](N)C)=O)CC2=CC=C(C=C2)O)=O)CC3=CC=CC=C3)=O)C(N4[C@@H](CCC4)C(N[C@@H](CCC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O.CC(O)=O.[x]

C46H59N7O12.xC2H4O2

902.00 (free base)

[1]M del Mar Contreras, et al. "Novel casein-derived peptides with antihypertensive activity." International dairy journal 19.10 (2009) : 566-573.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10601A/αs1-CN-f-143-149-acetate-SDS-MedChemExpress.pdf

Peptides

No Development Reported